<div class="at-above-post addthis tool" data-url="https://www.metro.us/european-nations-say-covid/"></div>BRUSSELS (Reuters) – Many European nations say they are receiving lower-than-expected supplies of COVID-19 vaccines as U.S. pharmaceutical giant Pfizer slows shipments and distribution proceeds unevenly among European Union states. Vaccines developed by Pfizer with its German partner BioNTech started being delivered in the EU at the end of December. U.S. biotech firm Moderna began […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https://www.metro.us/european-
Pfizer initially said vaccine deliveries were proceeding ‘according to the schedule agreed.’ But later on Friday it said there would be a temporary impact on shipments in late January to early February
Speaking to EU Parliamentarians on Tuesday, Director General of the European Commission for Health and Food Safety Sandra Gallina defended her institution’s procedure on procuring COVID-19 vaccines after criticism from some German Parliamentarians and Czech Prime Minister Andrej Babiš, who has stated that the Commission “overslept” on the issue.
Ms. Gallina said that the joint union-wide effort to procure the vaccine secured greater leverage than any individual state could have had. Problems related to vaccine production prove that the European Commission was right not to rely on a single producer and the maximum possible number of vaccines was procured, she said.